Authors:
Wurzner, G
Chiolero, A
Maillard, M
Nussberger, J
Hayoz, D
Brunner, HR
Burnier, M
Citation: G. Wurzner et al., Renal and neurohormonal responses to increasing levels of lower body negative pressure in men, KIDNEY INT, 60(4), 2001, pp. 1469-1476
Authors:
Wang, Q
Hummler, E
Maillard, M
Nussberger, J
Rossier, BC
Brunner, HR
Burnier, M
Citation: Q. Wang et al., Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous mice, KIDNEY INT, 59(6), 2001, pp. 2216-2221
Authors:
Meneton, P
Bloch-Faure, M
Hagege, AA
Ruetten, H
Huang, W
Bergaya, S
Ceiler, D
Gehring, D
Martins, I
Salmon, G
Boulanger, CM
Nussberger, J
Crozatier, B
Gasc, JM
Heudes, D
Bruneval, P
Doetschman, T
Menard, J
Alhenc-Gelas, F
Citation: P. Meneton et al., Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice, P NAS US, 98(5), 2001, pp. 2634-2639
Authors:
Burnier, M
Monod, ML
Chiolero, A
Maillard, M
Nussberger, J
Brunner, HR
Citation: M. Burnier et al., Renal sodium handling in acute and chronic salt loading/depletion protocols: the confounding influence of acute water loading, J HYPERTENS, 18(11), 2000, pp. 1657-1664
Authors:
Chiolero, A
Maillard, M
Nussberger, J
Brunner, HR
Burnier, M
Citation: A. Chiolero et al., Proximal sodium reabsorption - An independent determinant of blood pressure response to salt, HYPERTENSIO, 36(4), 2000, pp. 631-637
Authors:
Mazzolai, L
Pedrazzini, T
Nicoud, F
Gabbiani, G
Brunner, HR
Nussberger, J
Citation: L. Mazzolai et al., Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice, HYPERTENSIO, 35(4), 2000, pp. 985-991
Authors:
Maillard, MP
Rossat, J
Nussberger, J
Ramis, J
Pontes, C
Burnier, M
Brunner, HR
Citation: Mp. Maillard et al., Pharmacologic profile of UR-7247, an orally active angiotensin II AT(1) receptor antagonist, in healthy volunteers, J CARDIO PH, 35(3), 2000, pp. 383-389
Authors:
Rousso, P
Buclin, T
Nussberger, J
Brunner-Ferber, F
Brunner, HR
Biollaz, J
Citation: P. Rousso et al., Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers, EUR J CL PH, 55(10), 2000, pp. 749-754
Authors:
Schieffer, B
Schieffer, E
Hilfiker-Kleiner, D
Hilfiker, A
Kovanen, PT
Kaartinen, M
Nussberger, J
Harringer, W
Drexler, H
Citation: B. Schieffer et al., Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques - Potential implications for inflammation and plaque instability, CIRCULATION, 101(12), 2000, pp. 1372-1378
Authors:
Maillard, MP
Mazzolai, L
Daven, V
Centeno, C
Nussberger, J
Brunner, HR
Burnier, M
Citation: Mp. Maillard et al., Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay, AM J HYPERT, 12(12), 1999, pp. 1201-1208
Authors:
Rousso, P
Buclin, T
Nussberger, J
Decosterd, LA
La Roche, SD
Brunner-Ferber, F
Brunner, HR
Biollaz, J
Citation: P. Rousso et al., Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100 240, on endocrine and renal functions in healthy volunteers, J HYPERTENS, 17(3), 1999, pp. 427-437
Authors:
Mazzolai, L
Maillard, M
Rossat, J
Nussberger, J
Brunner, HR
Burnier, M
Citation: L. Mazzolai et al., Angiotensin II receptor blockade in normotensive subjects - A direct comparison of three AT(1) receptor antagonists, HYPERTENSIO, 33(3), 1999, pp. 850-855
Authors:
Haefliger, JA
Waeber, B
Grouzmann, E
Braissant, O
Nussberger, J
Nicod, P
Waeber, G
Citation: Ja. Haefliger et al., Cellular localization, expression and regulation of neuropeptide Y in kidneys of hypertensive rats, REGUL PEPT, 82(1-3), 1999, pp. 35-43
Authors:
Burnier, M
Fricker, AF
Hayoz, D
Nussberger, J
Brunner, HR
Citation: M. Burnier et al., Pharmacokinetic and pharmacodynamic effects of YM087, a combined V-1/V-2 vasopressin receptor antagonist in normal subjects, EUR J CL PH, 55(9), 1999, pp. 633-637
Authors:
Rossat, J
Maillard, M
Nussberger, J
Brunner, HR
Burnier, M
Citation: J. Rossat et al., Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects, CLIN PHARM, 66(1), 1999, pp. 76-84